Trial intelligence / Profile preview

Phase 2 randomized placebo-controlled study of TMC435350 with or without peginterferon alfa-2a and ribavirin in genotype 1 chronic hepatitis C

NL-OMON22664Phase 2Not yet recruiting

Sponsor

Janssen Pharmaceutical

Start

Dec 2007

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1